First-line atezolizumab monotherapy versus single-agent chemotherapy in patients with non-small-cell lung cancer ineligible for treatment with a platinum-containing regimen (IPSOS): a phase 3, global, multicentre, open-label, randomised controlled study
Titel:
First-line atezolizumab monotherapy versus single-agent chemotherapy in patients with non-small-cell lung cancer ineligible for treatment with a platinum-containing regimen (IPSOS): a phase 3, global, multicentre, open-label, randomised controlled study
Auteur:
Lee, Siow Ming Schulz, Christian Prabhash, Kumar Kowalski, Dariusz Szczesna, Aleksandra Han, Baohui Rittmeyer, Achim Talbot, Toby Vicente, David Califano, Raffaele Cortinovis, Diego Le, Anh Tuan Huang, Dingzhi Liu, Geoffrey Cappuzzo, Federico Reyes Contreras, Jessica Reck, Martin Palmero, Ramon Mak, Milena Perez Hu, Youyou Morris, Stefanie Höglander, Elen Connors, Mary Biggane, Alice M Vollan, Hans Kristian Peters, Solange